Type 2 Diabetes

In a 15,000-plus patient analysis that spanned more than 7 years, aspirin reduced vascular risks in patients—but also increased their rate of major bleeding events.

The new test should replace the water deprivation test as the new standard of care, investigators say.

Patients with T2DM who fasted 2 days a week had weight loss and metabolic outcomes similar to patients who followed a daily kcal-restricted diet.

The celebrity chef-turned-producer wants to champion healthcare access, both on the screen and in person. Where does he start?

The results of a new study point to age-related macular degeneration, diabetic retinopathy, and glaucoma as potential early warning signs that an individual is at risk for developing Alzheimer disease or dementia.

The optimal duration of dual antiplatelet therapy remains unclear, despite being proven efficacious for roughly 2 decades.

The device supplants Abbott's own 10-day Libre system as the longest-lasting self-applied continuous glucose monitoring system on the US market.

Kidney function decline tends to be more rapid among diabetes patients vs patients without diabetes, according to a new study. 

A probiotic a day may help keep bone loss at bay, according to a new study. 

The paradigm of obesity is complex and requires a multi-disciplinary approach, but it is one of the most gratifying experiences for both the physicians and patient when they see the results of weight loss.

Antipsychotic medications may not cause type 2 diabetes but a new review find the drugs may accelerate development of the disease. How can you protect your patients?

Positive data for the add-on therapy for patients with type 2 diabetes and chronic kidney disease will be presented at an upcoming medical meeting.

The Cleveland Clinic’s pioneer of minority programs plans to end health disparity.

To the knowledge of researchers, this is the first demonstration to show C3a can stimulate basal deposit production by normal human RPE cells.

Peter Toth, MD, spoke about the importance of noting elevated triglycerides in patients at risk for cardiovascular conditions.

New research suggests cirrhosis, not HCV status, is the reason diabetes rates are higher among HCV-infected patients.

Targeting metabolism with therapies such as metformin has shown in clinical settings to affect aging itself. In IPF, it could influence the rate of aging as well.

The risk of obesity was reduced by 75% for those children whose mothers partook in all 5 of the considered low-risk lifestyle factors compared to those whose mothers adhered to none.

AF is associated with major disease burden, predominately in the form of cardiovascular comorbidities. As a direct oral anti-coagulant, rivaroxaban has been a proven inhibitor of ischemic stroke risks in patients with AF.

The poster presentations included a meta-analysis of 17 studies analyzing the cost-effectiveness and performance of the CGM system and a real-world examination of the trends its use.

Tim Dunn, PhD, discussed the benefits that the Freestyle Libre continuous glucose monitoring system provides for both the patients and providers

In a comparison of canagliflozin to other SGLT-2 inhibitors and anti-hyperglycemic therapies, the drug was found to decrease hospitalization from heart failure risk, and carry no extra risk for leg or foot amputation.

Murray Stewart, MD, spoke about his research into the hormone leptin—a major player in appetite and metabolism, with much that's still misunderstood about it.

The addition of features such as Bluetooth and Wi-Fi connectivity, in addition to cloud-to-cloud integration, is essential to improving diabetes devices.

How telehealth-friendly devices could change standard of diabetes care — with the help of physicians, patients, and the overall health care system.